טוען...

Regorafenib treatment outcome for Taiwanese patients with metastatic gastrointestinal stromal tumors after failure of imatinib and sunitinib: A prospective, non-randomized, single-center study

The present study aimed to conduct a prognosis analysis of Taiwanese patients with metastatic gastrointestinal stromal tumors (GISTs), who are resistant to or were unable to tolerate imatinib or sunitinib, and were subsequently treated with regorafenib. The study considered the survival, potential p...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Oncol Lett
Main Authors: Hu, Chia-Hsiang, Yeh, Chun-Nan, Chen, Jen-Shi, Tsai, Chun-Yi, Wang, Shang-Yu, Cheng, Chi-Tung, Yeh, Ta-Sen
פורמט: Artigo
שפה:Inglês
יצא לאור: D.A. Spandidos 2020
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7400021/
https://ncbi.nlm.nih.gov/pubmed/32782530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.11756
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!